Diagnostic Accuracy and Cost Savings Associated with Dermoscopy: An Economic Study

Abstract

Cutaneous malignancies are the most common overall cancer worldwide. Dermoscopy is widely used among various specialties to evaluate skin lesions and to differentiate benign from malignant lesions. Our objective was to evaluate the diagnostic capability and the economic impact of dermoscopy. The accuracy of diagnoses and economic costs of treating skin lesions were compared between two periods: 2001 to 2007 (prior the use of dermoscopy) and 2009 to 2011 (following implementation of dermoscopy). During the earlier period, 6,549 skin lesions were excised, of which 1,042 (15.9%) were malignant. During the later period, 2,578 lesions were excised, of which 610 (23.7%) were malignant. The potential savings estimated for the Israeli health care system are 6,500,000 USD. The use of dermoscopy increases sensitivity in diagnosing malignant skin lesions, enables diagnoses at an earlier stage, and has the potential for major cost savings for the health care system.

Keywords

dermoscopy - basal cell carcinoma - squamous cell carcinoma - melanoma - health care system - economic impact

Publication History

Article published online:
13 June 2022

• References

• 1 Simionescu O, Blum A, Grigore M, Costache M, Avram A, Testori A. Learning from mistakes: errors in approaches to melanoma and the urgent need for updated national guidelines. Int J Dermatol 2016; 55 (09) 970-976
• 2 Duarte AF, Sousa-Pinto B, Azevedo LF. et al. Clinical ABCDE rule for early melanoma detection. Eur J Dermatol 2021; 31 (06) 771-778
• 3 Friedman RJ, Rigel DS, Kopf AW. Early detection of malignant melanoma: the role of physician examination and self-examination of the skin. CA Cancer J Clin 1985; 35 (03) 130-151
• 4 Apalla Z, Lallas A, Sotiriou E, Lazaridou E, Ioannides D. Epidemiological trends in skin cancer. Dermatol Pract Concept 2017; 7 (02) 1-6
• 5 Khazaei Z, Ghorat F, Jarrahi AM, Adineh HA, Sohrabivafa M, Goodarzi E. Global incidence and mortality of skin cancer by histological subtype and its relationship with the Human Development Index (HDI)—an ecology study in 2018. WCRJ 2019; 6: e1265
• 6 Cancer Facts & Figures. 2019 | American Cancer Society.
• 7 Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018; 68 (06) 394-424
• 8 Whiteman DC, Whiteman CA, Green AC. Childhood sun exposure as a risk factor for melanoma: a systematic review of epidemiologic studies. Cancer Causes Control 2001; 12 (01) 69-82
• 9 Lin JS, Eder M, Weinmann S. Behavioral counseling to prevent skin cancer: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 2011; 154 (03) 190-201
• 10 Sella T, Goren I, Shalev V. et al. Incidence trends of keratinocytic skin cancers and melanoma in Israel 2006-11. Br J Dermatol 2015; 172 (01) 202-207
• 11 Matthews NH, Li WQ, Qureshi AA, Weinstock MA, Cho E. Epidemiology of melanoma. In: Ward WH, Farma JM. eds. Cutaneous Melanoma: Etiology and Therapy. Singapore: Codon Publications; 2017
• 12 Rogers III RS. Malignant melanoma in the 21st century. Int J Dermatol 2000; 39 (03) 178-179
• 13 Kopf AW, Salopek TG, Slade J, Marghoob AA, Bart RS. Techniques of cutaneous examination for the detection of skin cancer. Cancer 1995; 75 (2, Suppl): 684-690
• 14 Goodson AG, Grossman D. Strategies for early melanoma detection: approaches to the patient with nevi. J Am Acad Dermatol 2009; 60 (05) 719-735 , quiz 736–738
• 15 Rigel DS, Russak J, Friedman R. The evolution of melanoma diagnosis: 25 years beyond the ABCDs. CA Cancer J Clin 2010; 60 (05) 301-316
• 16 Bränström R, Hedblad MA, Krakau I, Ullén H. Laypersons' perceptual discrimination of pigmented skin lesions. J Am Acad Dermatol 2002; 46 (05) 667-673
• 17 Argenziano G, Soyer HP. Dermoscopy of pigmented skin lesions—a valuable tool for early diagnosis of melanoma. Lancet Oncol 2001; 2 (07) 443-449
• 18 Binder M, Schwarz M, Winkler A. et al. Epiluminescence microscopy. A useful tool for the diagnosis of pigmented skin lesions for formally trained dermatologists. Arch Dermatol 1995; 131 (03) 286-291
• 19 Nachbar F, Stolz W, Merkle T. et al. The ABCD rule of dermatoscopy. High prospective value in the diagnosis of doubtful melanocytic skin lesions. J Am Acad Dermatol 1994; 30 (04) 551-559
• 20 Braun RP, Saurat JH, French LE. Dermoscopy of pigmented lesions: a valuable tool in the diagnosis of melanoma. Swiss Med Wkly 2004; 134 (7-8): 83-90
• 21 Kittler H, Pehamberger H, Wolff K, Binder M. Diagnostic accuracy of dermoscopy. Lancet Oncol 2002; 3 (03) 159-165
• 22 Bafounta ML, Beauchet A, Aegerter P, Saiag P. Is dermoscopy (epiluminescence microscopy) useful for the diagnosis of melanoma? Results of a meta-analysis using techniques adapted to the evaluation of diagnostic tests. Arch Dermatol 2001; 137 (10) 1343-1350
• 23 Vestergaard ME, Macaskill P, Holt PE, Menzies SW. Dermoscopy compared with naked eye examination for the diagnosis of primary melanoma: a meta-analysis of studies performed in a clinical setting. Br J Dermatol 2008; 159 (03) 669-676
• 24 Tromme I, Sacré L, Hammouch F. et al; DEPIMELA study group. Availability of digital dermoscopy in daily practice dramatically reduces the number of excised melanocytic lesions: results from an observational study. Br J Dermatol 2012; 167 (04) 778-786
• 25 Menzies SW, Emery J, Staples M. et al. Impact of dermoscopy and short-term sequential digital dermoscopy imaging for the management of pigmented lesions in primary care: a sequential intervention trial. Br J Dermatol 2009; 161 (06) 1270-1277
• 26 Holmes GA, Vassantachart JM, Limone BA, Zumwalt M, Hirokane J, Jacob SE. Using dermoscopy to identify melanoma and improve diagnostic discrimination. Fed Pract 2018; 35 (Suppl. 04) S39-S45
• 27 Wolner ZJ, Yélamos O, Liopyris K, Rogers T, Marchetti MA, Marghoob AA. enhancing skin cancer diagnosis with dermoscopy. Dermatol Clin 2017; 35 (04) 417-437
• 28 Bibbins-Domingo K, Grossman DC, Curry SJ. et al; US Preventive Services Task Force. Screening for skin cancer: US preventive services task force recommendation statement. JAMA 2016; 316 (04) 429-435